RT Conference Proceedings
T1 FACTORS ASSOCIATED WITH PERSISTENCE OF GOLIMUMAB TREATMENT IN THE BIOBADASER REGISTRY, UP TO 7 YEARS OF FOLLOW-UP
A1 Pombo, M.
A1 Sanchez-Piedra, C.
A1 Cea-Calvo, L.
A1 Manrique Arija, S.
A1 Garcia-Magallon, B.
A1 Campos Fernandez, C.
A1 Notario, I.
A1 Diaz-Gonzalez, F.
A1 Gomez-Reino, J. J.
PB Bmj publishing group
SN 0003-4967
YR 2020
FD 2020-06-01
LK https://hdl.handle.net/10668/26332
UL https://hdl.handle.net/10668/26332
LA en
DS RISalud
RD Apr 14, 2025